Type(s) of Cancer
Breast
Breast
Study Phase
Phase 3
Study Completion Date
January 2015
January 2015
NCT00070564Uploaded 08-12-2017
Access via NCI by Request
PDS UID: nci-data-348
Phase III Trial of Continuous Schedule AC + G vs. Q 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node-Negative Breast Cancer
Files: NCT00070564-D2
Data DictionaryNCT00070564-D2-Data-Dictionary.pdf
DATANCT00070564-D2-Dataset.txt
OTHERREADME.pdf
Files: NCT00070564-D1
Data DictionaryNCT00070564-D1-Data-Dictionary.pdf
DATANCT00070564-D1-Dataset.txt
OTHERREADME.pdf